These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25797791)

  • 1. Statistical prediction of nanoparticle delivery: from culture media to cell.
    Brown MR; Hondow N; Brydson R; Rees P; Brown AP; Summers HD
    Nanotechnology; 2015 Apr; 26(15):155101. PubMed ID: 25797791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the cellular uptake of semiconductor quantum dot nanoparticles by analytical electron microscopy.
    Hondow N; Brown MR; Starborg T; Monteith AG; Brydson R; Summers HD; Rees P; Brown A
    J Microsc; 2016 Feb; 261(2):167-76. PubMed ID: 25762522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle hardness controls the internalization pathway for drug delivery.
    Li Y; Zhang X; Cao D
    Nanoscale; 2015 Feb; 7(6):2758-69. PubMed ID: 25585060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular uptake, transport, and processing of gold nanostructures.
    Chithrani DB
    Mol Membr Biol; 2010 Oct; 27(7):299-311. PubMed ID: 20929337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow field-flow fractionation for the analysis of nanoparticles used in drug delivery.
    Zattoni A; Roda B; Borghi F; Marassi V; Reschiglian P
    J Pharm Biomed Anal; 2014 Jan; 87():53-61. PubMed ID: 24012480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted transport characteristics of nanomedicine: needs for characterization in dynamic environment.
    Ozcelikkale A; Ghosh S; Han B
    Mol Pharm; 2013 Jun; 10(6):2111-26. PubMed ID: 23517188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flotillin-involved uptake of silica nanoparticles and responses of an alveolar-capillary barrier in vitro.
    Kasper J; Hermanns MI; Bantz C; Utech S; Koshkina O; Maskos M; Brochhausen C; Pohl C; Fuchs S; Unger RE; Kirkpatrick CJ
    Eur J Pharm Biopharm; 2013 Jun; 84(2):275-87. PubMed ID: 23183446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of stable colloidal nanoparticles with cellular membranes.
    Mahmoudi M; Meng J; Xue X; Liang XJ; Rahman M; Pfeiffer C; Hartmann R; Gil PR; Pelaz B; Parak WJ; Del Pino P; Carregal-Romero S; Kanaras AG; Tamil Selvan S
    Biotechnol Adv; 2014; 32(4):679-92. PubMed ID: 24361955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and stability of nickel/nickel oxide core-shell nanoparticles.
    D'Addato S; Grillo V; Altieri S; Tondi R; Valeri S; Frabboni S
    J Phys Condens Matter; 2011 May; 23(17):175003. PubMed ID: 21493971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring agglomerate size distribution and dependence of localized surface plasmon resonance absorbance on gold nanoparticle agglomerate size using analytical ultracentrifugation.
    Zook JM; Rastogi V; Maccuspie RI; Keene AM; Fagan J
    ACS Nano; 2011 Oct; 5(10):8070-9. PubMed ID: 21888410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
    Hariri G; Edwards AD; Merrill TB; Greenbaum JM; van der Ende AE; Harth E
    Mol Pharm; 2014 Jan; 11(1):265-75. PubMed ID: 24215299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of antibody reagents for detecting nanoparticles.
    Ravichandran S; Sullivan MA; Callahan LM; Bentley KL; DeLouise LA
    Nanoscale; 2015 Dec; 7(47):20042-54. PubMed ID: 26568258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.